Unlike existing and first-generation immunotherapies that exclusively target immune T cells, these monoclonal antibodies are engineered to precise ...

Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the progression of liver cancer in those patients who cannot be treated with surgery, ...

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...

James “Jimmy” Carter, the 39th President of the United States, passed away last week on December 29, after 22 months in Hospice care.  At | Cancer ...

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

The past 12 months have seen the FDA approvals of enfortumab vedotin plus pembrolizumab for patients with locally advanced or ...

The European Society for Medical Oncology (ESMO) Congress featured findings on overall survival, disparities, and artificial ...

The following is a summary of “A potential inflammatory biomarker for advanced endometrial cancer treated with lenvatinib ...

High levels of immune infiltrates are strongly prognostic for favorable outcomes independently of nodal status in ...

Lenvatinib plus pembrolizumab did not improve PFS or OS over chemotherapy in patients with advanced or recurrent endometrial ...

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...